Electrophysiological assessment of the effects of antidepressant treatments on the efficacy of 5-HT neurotransmission
- PMID: 2846168
Electrophysiological assessment of the effects of antidepressant treatments on the efficacy of 5-HT neurotransmission
Abstract
The efficacy of serotoninergic (5-HT) neurotransmission was assessed in the rat brain following different types of antidepressant treatments. First, the firing rate of 5-HT neurons was assessed. Second, the responsiveness of postsynaptic neurons to 5-HT was evaluated by applying directly onto these neurons the neurotransmitter by microiontophoresis. Finally, the effect of the electrical stimulation of the 5-HT pathway on the firing activity of the same postsynaptic neurons was studied in order to determine the efficacy of synaptic transmission. Long-term administration of tricyclic antidepressant drugs induces a sensitization of rat forebrain neurons to 5-HT without altering 5-HT neuron properties. This sensitization results in an enhancement of the effect of the stimulation of the 5-HT pathway on the firing activity of postsynaptic neurons. Long-term administration of antidepressant monoamine oxidase inhibitors also results in an enhancement of the effectiveness of the stimulation of the 5-HT pathway. This is not due to a modification of postsynaptic neuron properties, since there is no enhancement of their responsiveness to 5-HT. Furthermore, the function of the terminal 5-HT autoreceptor is not altered by long-term treatment with a monoamine oxidase inhibitor. Therefore, the enhancement of 5-HT neurotransmission produced by this type of drugs is due to an increased availability of releasable 5-HT. The acute administration of 5-HT reuptake blockers does not enhance the efficacy of the stimulation of the 5-HT pathway. However, their long-term administration produces such an enhancement without altering the responsiveness of postsynaptic neurons to 5-HT. This modification of 5-HT transmission is attributable to a desensitization of the terminal 5-HT autoreceptor, thereby allowing a greater amount of 5-HT to be released per impulse in the synaptic cleft. The electrophysiological assessment of the effects of these different types of antidepressant treatments on the 5-HT system therefore revealed as a common effect an enhancement of 5-HT neurotransmission, albeit each one achieving this via a different mechanism.
Similar articles
-
Enhancement of the 5-HT neurotransmission by antidepressant treatments.J Physiol (Paris). 1981;77(2-3):455-61. J Physiol (Paris). 1981. PMID: 6270317
-
Effects of short-term serotonin depletion on the efficacy of serotonin neurotransmission: electrophysiological studies in the rat central nervous system.Synapse. 1990;6(4):328-37. doi: 10.1002/syn.890060404. Synapse. 1990. PMID: 1962911
-
Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system.J Pharmacol Exp Ther. 1986 Jun;237(3):987-94. J Pharmacol Exp Ther. 1986. PMID: 2423685
-
Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression.J Clin Psychopharmacol. 1987 Dec;7(6 Suppl):24S-35S. J Clin Psychopharmacol. 1987. PMID: 3323264 Review.
-
A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence.J Clin Psychiatry. 1990 Apr;51 Suppl:14-20; discussion 21. J Clin Psychiatry. 1990. PMID: 2157700 Review.
Cited by
-
Monitoring serotonin signaling on a subsecond time scale.Front Integr Neurosci. 2013 Jun 5;7:44. doi: 10.3389/fnint.2013.00044. eCollection 2013. Front Integr Neurosci. 2013. PMID: 23760548 Free PMC article.
-
Genetic inactivation of the Serotonin(1A) receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety.J Neurosci. 2000 Apr 15;20(8):2758-65. doi: 10.1523/JNEUROSCI.20-08-02758.2000. J Neurosci. 2000. PMID: 10751426 Free PMC article.
-
Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder.Psychopharmacology (Berl). 1991;105(3):415-20. doi: 10.1007/BF02244438. Psychopharmacology (Berl). 1991. PMID: 1686817 Clinical Trial.